Properties
Description
Acrizanib is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against VEGFR. It targets VEGFR2.
Molecular Formula
C20H18F3N7O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Acrizanib targets VEGFR and is used for research on anti-angiogenic compounds in cancer therapy.
